Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile - Wikidata - wikimedia - TriplyDB

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile

http://www.wikidata.org/entity/Q30440296

about

Ghrelin - a pleiotropic hormone secreted from endocrine x/a-like cells of the stomach Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved.Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice Association of plasma des-acyl ghrelin levels with CKD The ghrelin axis in disease: potential therapeutic indications.Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?What can anorexia nervosa teach us about appetite regulation?Intrarenal ghrelin infusion stimulates distal nephron-dependent sodium reabsorption in normal rats.Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations Wasting in chronic kidney disease Update on melanocortin interventions for cachexia: progress toward clinical application.Animal models of anorexia and cachexia.Therapeutic Potential of Targeting the Ghrelin Pathway.Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease.New insights into the role of anabolic interventions in dialysis patients with protein energy wasting.Ghrelin in chronic kidney disease.Metabolic and cardiovascular effects of ghrelin Integrating GHS into the Ghrelin System.Hypothalamic mechanisms in cachexia.Effect of feeding status on adjuvant arthritis severity, cachexia, and insulin sensitivity in male Lewis rats.Ghrelin gene products in acute and chronic inflammation.Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome Ghrelin for cachexia.Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia.Pathophysiology and treatment of inflammatory anorexia in chronic disease.Neuropeptides in the pathophysiology and treatment of cachexia.Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers Emerging treatments in Neurogastroenterology: relamorelin: a novel gastrocolokinetic synthetic ghrelin agonist.The Pentapeptide RM-131 Promotes Food Intake and Adiposity in Wildtype Mice but Not in Mice Lacking the Ghrelin Receptor Exploring metabolic dysfunction in chronic kidney disease.Interaction between acyl-ghrelin and BMI predicts clinical outcomes in hemodialysis patients Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats Neural control of the anorexia-cachexia syndrome.Association of genetic variants of ghrelin, leptin and UCP2 with malnutrition inflammation syndrome and survival in end-stage renal disease patients.Hormonal regulators of appetite.Cachexia and sarcopenia: emerging syndromes of importance in dogs and cats.Ghrelin and cachexia in chronic kidney disease.Can treating persistent inflammation limit protein energy wasting?Ghrelin and leptin pathophysiology in chronic kidney disease.Deletion of ghrelin prevents aging-associated obesity and muscle dysfunction without affecting longevity.

P2860

Q21129364-D2E757A0-3D26-4C60-A0BE-0396295E7B90 Q30384810-056F26AA-376D-40C9-91F0-1803D6CC4A3E Q30410972-ADCEC6EF-BA98-432B-A708-FF21983AF463 Q30412038-B9364DFE-1C8A-4C84-85D3-63386A5FDA95 Q30426399-D09EC855-2AF9-4FDD-9174-0ECA5E5F2521 Q30426403-520B000F-6C76-4BB9-96D7-CDED7E164B33 Q30427681-242BDCE8-1015-4015-9C29-CE6B6DCA8125 Q30428081-A019F432-1804-4806-9E40-82938CBC956A Q30431058-E298D70D-FA02-4B90-A2A2-941973B67F76 Q30432774-D963AB8F-4CAB-42AD-A47A-DAC98B71CBF3 Q30433378-5A64B2B4-E942-48D9-9A20-DF6DC2B2799D Q30434298-B2B64ADE-F628-4AFE-B926-2FE2EB6C7516 Q33624632-19CDDE34-EE4B-43A2-B03C-DEC682094526 Q33802142-0FEEA942-46D9-48D7-9520-980729AC1B1E Q33935889-C6CA2C27-0C28-4F0F-83FA-0006D4B1F5FC Q34043086-F164B5C1-E298-4970-8EC7-FBA9F5485E84 Q34078358-3E7C61A2-49FB-42E9-AE9E-037C556D0FC8 Q34078389-9A515FE5-DD10-402E-AADA-F8625E42C60C Q34081332-2346EF12-39BF-4249-84AC-E38CF3C0DB9C Q34189534-CF72B68E-E895-4569-B802-9B205AE627DA Q34414977-6600AE98-2829-428F-A587-E61F5F3F8BD8 Q34669261-196A45BC-6D74-4E8E-B845-7183445CCBA3 Q34697171-26F9FE5A-49BC-46BF-80EE-74467BFCFB0C Q34697244-6D204C92-802E-451E-A722-C90E082E078D Q34697279-21D05D1D-8061-4016-8AB9-5DBA1BEC75DF Q34712204-227BF466-DB49-46E7-92D1-32491C79BF5F Q35173639-39BF635E-18C6-486A-B9FF-E4DD05FB4F18 Q35584740-CFEBE1EB-AADF-4A5D-85A0-EAF2F35C3F64 Q35596484-4D951119-330F-480B-AC4C-8554E89DBA9B Q36123347-2F982CE5-3C4D-4F1D-BC82-4BD486848BFD Q36252993-1BBB5FA9-3435-4C4A-BF59-00BE495D9A21 Q36805444-7CF9C498-2453-48D8-8A8D-AA73A8088F59 Q37247483-363EBB89-CF28-4343-B704-E7410092CCA1 Q37300041-732DECF1-870E-4C7E-8129-62F00C1E3E09 Q37420818-748293EE-4501-4984-86AA-F3953D364C3F Q37960096-E193A5BA-1983-4A28-8F0D-2D0E3660E486 Q38023729-7AE91792-09AF-45A6-94B2-84E6DACCAFC8 Q38050186-6030617C-0774-45FD-99D5-E5CB68F1858D Q38066384-4C298E89-753A-4ADB-B5EC-62AD2B9CC3E3 Q40988846-2A276002-45BE-44EF-93F4-8BCC241D9E64

P2860

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile

http://www.wikidata.org/entity/Q30440296

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@ast

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@en

type

label

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@ast

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@en

prefLabel

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@ast

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@en

P1433

Q30440296-3F3356EE-A600-4D14-B472-A2497D68EF07

P1476

Q30440296-BE7D1B32-274D-46D8-9343-A16ED68D097D

P2093

Q30440296-0D0C940D-0775-4A81-A2CF-0E052DD8A3D9

Q30440296-1CE58E13-B4F4-49A3-AFB9-C91C26EFB4C9

Q30440296-2B3D8CE7-502A-42F3-B142-DE7DB5C6C449

Q30440296-4D457C5A-0229-4DE0-A1E3-997FCC70112F

Q30440296-6757633B-63F1-403B-AD57-5AF0CADFFABE

Q30440296-7E92F8CF-5393-446C-AC4C-843A6CC19DA3

Q30440296-C085A326-2E43-4355-B4D0-857C404A7970

Q30440296-C9696A30-4431-42D4-9A80-0A2DA7F38F28

Q30440296-CABEBB7B-C83D-45D0-81E5-5C373D503A5A

Q30440296-CC72F30F-6795-4EE4-B15F-033A98BF27CF

P2860

Q30440296-00BC8449-04AA-4B8B-A47A-E231BABCC20B

Q30440296-01BE168D-5658-431B-888D-57E39F514918

Q30440296-03714EC3-A7A8-45F0-BF43-4A1FD675AA48

Q30440296-03F64D55-354C-4820-BBFE-D8DF08A53330

Q30440296-117CC7CC-3DBF-49CC-AE05-205B87C79CDA

Q30440296-128FD1CF-4611-4096-BAA7-EAF23D5EEA20

Q30440296-329A5768-6121-4199-8C05-61CB6A7E0B4D

Q30440296-375B7670-0683-4F6F-8AE9-C850059DF715

Q30440296-3C7E30CE-B2F1-489D-AFD0-674142BACC19

Q30440296-3D8A0935-C918-4032-92B7-F5BC2127CB67

P304

Q30440296-6DE61A8F-E544-41A1-9819-C75615F6EABB

P31

Q30440296-891E9019-BD80-4C5F-81C1-AF00849FCE62

P356

Q30440296-CF3E2945-B8AC-485B-A30C-0BCA8373D579

P407

Q30440296-5F9C0971-27E2-4F88-925B-1DE3FA398861

P433

Q30440296-A0FA3DE8-1262-4280-9342-5BA6B0D662AA

P478

Q30440296-E0D6CCFD-0C76-4E09-98FC-1B02C5BD3317

P577

Q30440296-AD35594F-44C4-46E9-9091-1E9951C97098

P5875

Q30440296-94396E1F-8F32-4CDA-8CB5-F5A3E1C2E1C5

P698

Q30440296-F8E18B8B-463E-4DFC-B464-4CC996394D79

P932

Q30440296-C38AA962-74E4-4E01-889E-20FFDAC30751

P356

P1433

P1476

Ghrelin treatment of chronic k ...... body mass and cytokine profile

@en

P2093

Akio Inui

http://www.w3.org/2001/XMLSchema#string

Daniel L Marks

http://www.w3.org/2001/XMLSchema#string

Guofeng Han

http://www.w3.org/2001/XMLSchema#string

Heather A Halem

http://www.w3.org/2001/XMLSchema#string

Jesse Z Dong

http://www.w3.org/2001/XMLSchema#string

John E Taylor

http://www.w3.org/2001/XMLSchema#string

Mark D Deboer

http://www.w3.org/2001/XMLSchema#string

Michael D Culler

http://www.w3.org/2001/XMLSchema#string

Peter R Levasseur

http://www.w3.org/2001/XMLSchema#string

Rakesh Datta

http://www.w3.org/2001/XMLSchema#string

P2860

Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients

Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor

A role for ghrelin in the central regulation of feeding

Melanocortin interventions in cachexia: how soon from bench to bedside?

Mechanisms causing muscle proteolysis in uremia: the influence of insulin and cytokines.

Role of the central melanocortin system in cachexia.

Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia.

Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia.

Anatomy and regulation of the central melanocortin system.

Therapy insight: Use of melanocortin antagonists in the treatment of cachexia in chronic disease.

P304

827-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/EN.2007-1046

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

149

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5807608

http://www.w3.org/2001/XMLSchema#string

P698

18039782

http://www.w3.org/2001/XMLSchema#string

P932

2219314

http://www.w3.org/2001/XMLSchema#string